Correlation Between Akoya Biosciences and GlucoTrack

Can any of the company-specific risk be diversified away by investing in both Akoya Biosciences and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akoya Biosciences and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akoya Biosciences and GlucoTrack, you can compare the effects of market volatilities on Akoya Biosciences and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akoya Biosciences with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akoya Biosciences and GlucoTrack.

Diversification Opportunities for Akoya Biosciences and GlucoTrack

0.36

Correlation Coefficient

Akoya Biosciences  GlucoTrack

Weak diversification

The 3 months correlation between Akoya and GlucoTrack is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Akoya Biosciences and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and Akoya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akoya Biosciences are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of Akoya Biosciences i.e., Akoya Biosciences and GlucoTrack go up and down completely randomly.

Pair Corralation between Akoya Biosciences and GlucoTrack

Given the investment horizon of 90 days Akoya Biosciences is expected to generate 0.47 times more return on investment than GlucoTrack. However, Akoya Biosciences is 2.11 times less risky than GlucoTrack. It trades about 0.01 of its potential returns per unit of risk. GlucoTrack is currently generating about -0.2 per unit of risk. If you would invest  238.00  in Akoya Biosciences on September 2, 2024 and sell it today you would lose (18.00) from holding Akoya Biosciences or give up 7.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Akoya Biosciences  vs.  GlucoTrack

Akoya Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Akoya Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlucoTrack

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Akoya Biosciences and GlucoTrack

The main advantage of trading using opposite Akoya Biosciences and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akoya Biosciences position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.

The idea behind Akoya Biosciences and GlucoTrack pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..